Recipharm

The Challenge

Recipharm, a global leader in pharmaceutical contract development and manufacturing (CDMO), operates in a highly regulated and energy-intensive sector. With sustainability becoming a strategic priority, the company faced the challenge of reducing its carbon footprint while maintaining uncompromising standards in production and compliance. The goal was to find a solution that could deliver environmental impact and cost savings, without disrupting operations or requiring upfront capital investment.

The Solution

Eden Sustainable partnered with Recipharm to deliver a 1MW rooftop solar PV system at one of its UK facilities, funded entirely through Eden’s Power Purchase Agreement (PPA) model. This approach enabled Recipharm to access clean, low-cost electricity with zero upfront cost. Eden handled the full lifecycle of the project, from design and installation to ongoing operation and maintenance, ensuring the system was tailored to the site’s energy profile and regulatory requirements. The solar array now generates clean electricity directly on-site, reducing reliance on grid power and supporting Recipharm’s long-term sustainability goals.

The Outcome

The installation is expected to save Recipharm an average of £119,576 per year in electricity costs while cutting 172,920 kg of CO₂ emissions annually. The project demonstrates how Eden Sustainable’s PPA model can unlock renewable energy for industrial clients without financial barriers, delivering both environmental and economic value. This partnership highlights Eden’s ability to integrate solar into complex manufacturing environments, proving that sustainability and operational excellence can go hand in hand.